生物医学技术创新的风险及其协同治理OACHSSCD

Biomedical technologies—represented by gene editing,cognitive enhancement,cryopreservation and regen-eration,artificial wombs,and AI-assisted technologies—have significantly improved human health while simultaneously giving rise to multi-layered,systemic,and structural risks.The risks associated with biomedical technology innovation are,in essence,a form of technological alienation triggered by the excessive expansion of instrumental rationality and the deep penetration of capital logic.These risks manifest primarily in the alienation of scientific and technological ad-vancement,humanistic values,social equity,cognitive consensus,and institutional regulation.There is an urgent need to achieve a dynamic balance between technological development and ethical regulation through measures such as prior ethical review,strengthened informed consent,the promotion of technology as a public good,the establishment of a forward-looking and adaptive regulatory system,the creation of cross-sectoral coordination mechanisms,and the improve-ment of specialized legislation.These efforts aim to provide theoretical support and institutional solutions for the standard-ized and sound development of biomedical technologies in China,thereby facilitating the in-depth implementation of the"Healthy China"strategy.